Okay, let's tackle this question. The patient is a nine-month-old with progressive symptoms starting at 6 months. The key points are severe anemia (Hb 3.8 g%), microcytic hypochromic indices (MCV 58, MCH 19.4 pg), target cells, normoblasts in blood film, and expanded erythroid marrow on X-ray. Osmotic fragility is normal, which rules out hereditary spherocytosis.

First, the age is important. Nine months is around when infants transition from maternal iron stores to their own intake. If there's a genetic condition, it would present earlier. But the symptoms started at 6 months, which is when they start weaning and might have dietary changes. However, the blood film findings suggest a more intrinsic issue.

Microcytic anemia with target cells and normoblasts points towards thalassemia. Beta-thalassemia major typically presents in early childhood with severe anemia, and the lab findings match. The expanded marrow on X-ray is a sign of increased erythropoiesis due to ineffective hematopoiesis. Osmotic fragility being normal rules out hereditary spherocytosis, which is another cause of hemolytic anemia but presents with spherocytes, not target cells.

Looking at the options, the most likely is beta-thalassemia major. The other possibilities might include iron deficiency anemia, but that's usually microcytic with low ferritin and would have a different blood film (no target cells, maybe more hypochromia). Sideroblastic anemia could be a consideration, but the presence of normoblasts and the age point more towards thalassemia. Sickle cell anemia would present with different lab features and a different RBC morphology (sickle cells, not target cells).

So the correct answer is beta-thalassemia major. The distractors should be iron deficiency, hereditary spherocytosis, and sickle cell. Each of these is ruled out by the lab findings. The clinical pearl here is to remember that target cells and normoblasts in a microcytic anemia with family history suggest thalassemia. Thalassemia is more common in certain ethnic groups like Sindhi, so that's a high-yield point.

**Core Concept**
This question tests the differential diagnosis of microcytic anemia in an infant, focusing on morphological features, osmotic fragility, and marrow expansion. Key findings include target cells, normoblastemia, and normal osmotic fragility, which are classic for **beta-thalassemia major**.

**Why the Correct Answer is Right**
Beta-thalassemia major results from mutations in the beta-globin gene, leading to reduced beta-chain synthesis and excess alpha-globin tetramers. This causes ineffective erythropoiesis and hemolysis. Target cells and normoblasts in peripheral blood, along with erythroid marrow expansion on imaging, are hallmark features. The low MCV and MCH confirm microcytic anemia, while normal osmotic fragility excludes hereditary spherocytosis. Early presentation (before 2 years) and consanguinity (Sindhi parents) further support

✓ Correct Answer: C. Hemoglobin D disease